Skip to Content

Cardlytics, Inc.

Securities Class Action

  • Date:
  • 3/25/2025
  • Company Name:
  • Cardlytics, Inc.
  • Stock Symbol:
  • CDLX
  • Class Period:
  • FROM 3/14/2024 TO 8/7/2024
  • Status:
  • Filed
  • Filing Date:
  • 1/22/2025
  • Court:
  • U.S. District Court: Northern Georgia

Case Finder

Locate any case using the tools below.

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Cardlytics, Inc. (“Cardlytics” or the “Company”) (NASDAQ:CDLX) in the United States District Court for the Northern District of Georgia on behalf of all persons and entities who purchased or otherwise acquired Cardlytics securities between March 14, 2024 and August 7, 2024, both dates inclusive (the “Class Period”). Investors have until March 25, 2025 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

According to the lawsuit, throughout the Class Period, defendants made false and misleading statements and/or failed to disclose that: (1) increasing consumer engagement led to an increase in consumer incentives; (2) Cardlytics could not increase its billings commensurate with the increased consumer engagement; (3) as a result, there was a significant risk that its revenue growth would slow or decline; (4) the changes to Cardlytics’ Ads Decision Engine (“ADE”), which led to increased consumer engagement, led to the “underdelivery” of budgets and customers billing estimates; and (5) as a result of the foregoing, defendants’ positive statements about Cardlytics’ business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.
 
If you purchased or otherwise acquired Cardlytics shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at investigations@bespc.com, telephone at (212) 355-4648, or by filling out the form below.  There is no cost or obligation to you.
Contact Instructions
Please contact Brandon Walker by email at investigations@bespc.com with any questions about this case.
The individual or institution below (“Plaintiff”) has reviewed and agrees to the Bragar Eagel & Squire, P.C. (“BESPC”) retainer agreement and authorizes BESPC to prosecute an action on Plaintiff’s behalf under the federal securities laws or applicable state laws to recover damages on behalf of investors in Cardlytics. BESPC will prosecute the action on a full contingency basis and will forward all costs and expenses.
 

Case Finder

Locate any case using the tools below.

You may share a link to this page on any of the sites listed below or send link via email: